A randomized, parallel- group, 24 -blind, placebo-controlled, multicenter Phase 3 study to week,double assess the efficacy and safety of secukinumab compared to placebo in adult patients with active rotator cuff tendinopaty

Title

Code

CAIN457O12302

Type

Sperimentale con farmaco

Start Year

2024

Status

In Corso

Principal Investigator

051-6366386

francesco.ursini@ior.it

Prof. Ursini Francesco

Medicine and Rheumatology

Operational unit that carry out the study

departmental simple unit

Medicina e reumatologia

Temporary Head

Faldini Cesare, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. CAIN457O12302

Wednesday 31 January 2024, 09:49

PG0001331_2024_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

A randomized, parallel- group, 24 -blind, placebo-controlled, multicenter Phase 3 study to week,double assess the efficacy and safety of secukinumab compared to placebo in adult patients with active rotator cuff tendinopaty

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in